The Catalyze Preclinical Services Program is now accepting Expressions of Interest (EOI) to support early translational product development in heart, lung, blood, and sleep research.

This program hosted by NHLBI and managed by RTI International,  and provides milestone-driven preclinical support for small molecules, biologics, devices, diagnostics, and technologies.

Interested applicants must submit an EOI by February 13, 2026, after which selected projects will be invited to submit a full application. To learn more about the Catalyze program, click here.